from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2435c/-

LFCtreatmentdescriptionclass of inhibitor

-0.030

Amikacinug/mL Amikacintranslation

-0.770

Cap5-10ug/mL Capreomycintranslation

-0.117

Rox10-50 ug/mL Roxithromycintranslation

-0.132

SM2-5 ug/mL Streptomycintranslation

-1.723

Tet5-10 ug/mL Tetracyclinetranslation

1.139

Rif0.2-5ug/mL Rifampicintranscription

0.179

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.455

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.496

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.263

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.598

Clofazimine10-13 ug/mL Clofaziminerespiration

0.431

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.819

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.544

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.126

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.141

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.139

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.031

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.497

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.508

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.988

KCN5-20 ug/mL Potassium cyaniderespiration

-0.553

NaN30.2-2 mM Sodium aziderespiration

0.280

Nigericin50 uM Nigericinrespiration

-0.144

TRC10-150 ug/mL Triclosanrespiration

0.287

TRZ10-25 ug/mL Thioridazinerespiration

0.079

Valinomycin0.5-10 uM Valinomycinrespiration

0.372

ZnSO42 mM ZnSO4respiration

-0.961

menadione6-10 ug/mL Menadionerespiration

-0.354

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.196

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.292

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.345

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.897

NRP_1Non-replicating persistence stage 1dosRassociated

0.226

Amp0.2mg/mL AmpicillincellWall

0.364

Cephalexin20-100 ug/mL CephalexincellWall

0.043

Cerulenin0.32-5 ug/mL CerulenincellWall

0.722

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.265

EMB10-20 ug/mL EthambutolcellWall

-0.214

Eta12-40 ug/mL EthionamidecellWall

-0.313

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.399

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.841

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.007

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.687

BZA0.12 mg/mL BenzamidearomaticAmides

0.349

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.020

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.668

H2O24 mM hydrogen peroxideDNAdamaging

-0.361

Levo10 ug/mL LevofloxacinDNAdamaging

0.529

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.663

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.234

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.067

UVUV-irradiationDNAdamaging

-1.137

ARP41-4 ug/mL Antitubercular compound ARP4?

0.046

Antimycin12.5-50 ug/mL Antimycin A?

0.262

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.800

PA_110-50 ug/mL Antitubercular compound PA-1?

0.518

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.882

PA8240.2-2 ug/mL PA-824?

-0.995

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.092

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.005

Verapamil50 uM Verapamil?

1.102

mercaptoethanol2 mM 2-Mercaptoethanol?

0.244

methoxatin10-20 ug/mL Methoxatin?